403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Why Has The Centre Barred Certain Cold Medicines For Children Under Four?
(MENAFN- Live Mint) The Union health and family welfare ministry has restricted the manufacture, sale and distribution of all fixed-dose combinations containing chlorpheniramine maleate and phenylephrine hydrochloride for use in treating the common cold in infants and young children below four years of age, in India's ₹4,500 crore cough, cold and anti-allergic retail market.
The regulatory action follows safety recommendations from an expert committee and the Drugs Technical Advisory Board, against the backdrop of toxic syrup tragedies linked to contamination with diethylene glycol and ethylene glycol. Mint explains:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment